sf 6,5 has been researched along with Disease Exacerbation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aeed, H; Barg, J; Bruck, R; Halpern, Z; Hershkoviz, R; Lider, O; Matas, Z; Zaidel, L | 1 |
Aeed, H; Bruck, R; Halpern, Z; Hershkoviz, R; Lider, O; Shirin, H | 1 |
1 review(s) available for sf 6,5 and Disease Exacerbation
Article | Year |
---|---|
Non-peptidic analogs of the cell adhesion motif RGD prevent experimental liver injury.
Topics: Animals; Carcinogens; Concanavalin A; Disease Progression; Guanidines; Hepatitis, Autoimmune; Liver Cirrhosis, Experimental; Mice; Mitogens; Oligopeptides; Rats; Receptors, Immunologic; T-Lymphocytes; Thioacetamide; Transaminases; Tumor Necrosis Factor-alpha; Valerates | 2000 |
1 other study(ies) available for sf 6,5 and Disease Exacerbation
Article | Year |
---|---|
Inhibition of experimentally-induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-Gly-Asp epitope.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Biopsy; Carcinogens; Cell Adhesion; Disease Progression; Extracellular Matrix; Female; Fibronectins; Guanidines; Hemodynamics; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Oligopeptides; Rats; Rats, Wistar; Spleen; Thioacetamide; Valerates | 1996 |